• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌中 DNA 修复基因启动子甲基化的重新评估

A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma.

机构信息

1] Molecular Pathology Research and Development Laboratory, Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, Victoria, 8006, Australia [2] Translational Genomics and Epigenomics Laboratory, Ludwig Institute for Medical Research, Olivia Newton-John Cancer and Wellness Centre, Austin Hospital, Heidelberg, Victoria, 3084, Australia [3] Department of Pathology, University of Melbourne, Parkville, Victoria, 3010, Australia.

1] Translational Genomics and Epigenomics Laboratory, Ludwig Institute for Medical Research, Olivia Newton-John Cancer and Wellness Centre, Austin Hospital, Heidelberg, Victoria, 3084, Australia [2] Department of Pathology, University of Melbourne, Parkville, Victoria, 3010, Australia.

出版信息

Sci Rep. 2014 Feb 26;4:4186. doi: 10.1038/srep04186.

DOI:10.1038/srep04186
PMID:24569633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3935198/
Abstract

DNA repair genes that have been inactivated by promoter methylation offer potential therapeutic targets either by targeting the specific repair deficiency, or by synthetic lethal approaches. This study evaluated promoter methylation status for eight selected DNA repair genes (ATM, BRCA1, ERCC1, MGMT, MLH1, NEIL1, RAD23B and XPC) in 56 non-small cell lung cancer (NSCLC) tumours and 11 lung cell lines using the methylation-sensitive high resolution melting (MS-HRM) methodology. Frequent methylation in NEIL1 (42%) and infrequent methylation in ERCC1 (2%) and RAD23B (2%) are reported for the first time in NSCLC. MGMT methylation was detected in 13% of the NSCLCs. Contrary to previous studies, methylation was not detected in ATM, BRCA1, MLH1 and XPC. Data from The Cancer Genome Atlas (TCGA) was consistent with these findings. The study emphasises the importance of using appropriate methodology for accurate assessment of promoter methylation.

摘要

通过启动子甲基化失活的 DNA 修复基因提供了潜在的治疗靶点,既可以针对特定的修复缺陷,也可以通过合成致死的方法。本研究使用甲基化敏感高分辨率熔解(MS-HRM)方法,评估了 56 例非小细胞肺癌(NSCLC)肿瘤和 11 个肺细胞系中 8 个选定的 DNA 修复基因(ATM、BRCA1、ERCC1、MGMT、MLH1、NEIL1、RAD23B 和 XPC)的启动子甲基化状态。首次在 NSCLC 中报道了 NEIL1(42%)频繁甲基化和 ERCC1(2%)和 RAD23B(2%)罕见甲基化。MGMT 甲基化在 13%的 NSCLC 中被检测到。与之前的研究不同,ATM、BRCA1、MLH1 和 XPC 中未检测到甲基化。来自癌症基因组图谱(TCGA)的数据与这些发现一致。该研究强调了使用适当的方法来准确评估启动子甲基化的重要性。

相似文献

1
A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma.非小细胞肺癌中 DNA 修复基因启动子甲基化的重新评估
Sci Rep. 2014 Feb 26;4:4186. doi: 10.1038/srep04186.
2
Methylation status of O6-methylguanine-DNA-methyl transferase promoter region in non-small-cell lung cancer patients with brain metastasis.非小细胞肺癌脑转移患者 O6-甲基鸟嘌呤-DNA-甲基转移酶启动子区域的甲基化状态。
Clin Transl Oncol. 2012 Jan;14(1):31-5. doi: 10.1007/s12094-012-0758-6.
3
Determination of O⁶-methylguanine DNA methyltransferase promoter methylation in non-small cell lung cancer.非小细胞肺癌中O⁶-甲基鸟嘌呤DNA甲基转移酶启动子甲基化的测定
Genet Test Mol Biomarkers. 2011 May;15(5):357-60. doi: 10.1089/gtmb.2010.0211. Epub 2011 Feb 2.
4
Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.乳腺癌和肺癌中腺瘤性息肉病 coli(APC)基因启动子 1A 的异常甲基化。
Clin Cancer Res. 2001 Jul;7(7):1998-2004.
5
Aberrant promoter methylation of CDH13 and MGMT genes is associated with clinicopathologic characteristics of primary non-small-cell lung carcinoma.CDH13 和 MGMT 基因启动子异常甲基化与原发性非小细胞肺癌的临床病理特征相关。
Clin Lung Cancer. 2012 Jul;13(4):297-303. doi: 10.1016/j.cllc.2011.11.003. Epub 2011 Dec 13.
6
DNA methylation profiles of lung tumors.肺肿瘤的DNA甲基化图谱
Mol Cancer Ther. 2001 Nov;1(1):61-7.
7
Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.非小细胞肺癌中3号染色体p21.3区域的等位基因缺失及信号素3B的启动子高甲基化
Cancer Res. 2003 Jun 15;63(12):3352-5.
8
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.非小细胞肺癌中PTEN表达缺失可能与启动子甲基化有关。
Clin Cancer Res. 2002 May;8(5):1178-84.
9
Methylation of TMEFF2 gene in tissue and serum DNA from patients with non-small cell lung cancer.非小细胞肺癌患者组织和血清 DNA 中 TMEFF2 基因的甲基化。
Mol Cells. 2012 Aug;34(2):171-6. doi: 10.1007/s10059-012-0083-5. Epub 2012 Jul 18.
10
Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.中国非小细胞肺癌患者的异常启动子甲基化:原发性肿瘤模式及在支气管肺泡灌洗中的潜在诊断应用
Clin Cancer Res. 2002 Dec;8(12):3741-6.

引用本文的文献

1
Research progress on the role of the NEIL family in cancer.NEIL家族在癌症中作用的研究进展
Front Cell Dev Biol. 2025 Jul 21;13:1612329. doi: 10.3389/fcell.2025.1612329. eCollection 2025.
2
Cigarette smoke and decreased DNA repair by Xeroderma Pigmentosum Group C use a double hit mechanism for epithelial cell lung carcinogenesis.香烟烟雾和着色性干皮病C组导致的DNA修复能力下降通过双重打击机制引发上皮细胞肺癌。
Oncotarget. 2025 May 20;16:396-409. doi: 10.18632/oncotarget.28724.
3
Cigarette Smoke and Decreased DNA Repair by Xeroderma Pigmentosum Group C Use a Double Hit Mechanism for Epithelial Cell Lung Carcinogenesis.

本文引用的文献

1
DNA repair dysregulation from cancer driver to therapeutic target.DNA 修复失调:从癌症驱动因子到治疗靶点。
Nat Rev Cancer. 2012 Dec;12(12):801-17. doi: 10.1038/nrc3399.
2
Comprehensive genomic characterization of squamous cell lung cancers.全面基因组特征分析鳞状细胞肺癌
Nature. 2012 Sep 27;489(7417):519-25. doi: 10.1038/nature11404. Epub 2012 Sep 9.
3
DNA methylation biomarkers in cancer: progress towards clinical implementation.癌症中的 DNA 甲基化生物标志物:向临床应用的进展。
香烟烟雾与着色性干皮病C组DNA修复能力下降通过双打击机制引发上皮细胞肺癌
bioRxiv. 2025 Feb 27:2025.02.22.639660. doi: 10.1101/2025.02.22.639660.
4
The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC).DNA甲基化和DNA甲基转移酶(DNMTs)在非小细胞肺癌(NSCLC)中作为潜在生物标志物和治疗靶点的作用。
Heliyon. 2024 Sep 27;10(19):e38663. doi: 10.1016/j.heliyon.2024.e38663. eCollection 2024 Oct 15.
5
Epigenetic regulation in lung cancer.肺癌中的表观遗传调控。
MedComm (2020). 2023 Oct 26;4(6):e401. doi: 10.1002/mco2.401. eCollection 2023 Dec.
6
Identification of region-specific splicing QTLs in human hippocampal tissue and its distinctive role in brain disorders.人类海马组织中区域特异性剪接QTL的鉴定及其在脑部疾病中的独特作用。
iScience. 2023 Sep 19;26(10):107958. doi: 10.1016/j.isci.2023.107958. eCollection 2023 Oct 20.
7
The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer.免疫系统和分子细胞信号通路在肺癌发病机制和进展中的重要性。
Int J Mol Sci. 2023 Jan 12;24(2):1506. doi: 10.3390/ijms24021506.
8
Combined therapy with cisplatin and 5-AZA-2CdR modifies methylation and expression of DNA repair genes in oral squamous cell carcinoma.顺铂与5-氮杂-2'-脱氧胞苷联合治疗可改变口腔鳞状细胞癌中DNA修复基因的甲基化和表达。
Int J Clin Exp Pathol. 2022 Mar 15;15(3):131-144. eCollection 2022.
9
CDK1 and HSP90AA1 Appear as the Novel Regulatory Genes in Non-Small Cell Lung Cancer: A Bioinformatics Approach.CDK1和HSP90AA1作为非小细胞肺癌中的新型调控基因:一种生物信息学方法
J Pers Med. 2022 Mar 4;12(3):393. doi: 10.3390/jpm12030393.
10
Global DNA methylation profile at LINE-1 repeats and promoter methylation of genes involved in DNA damage response and repair pathways in human peripheral blood mononuclear cells in response to γ-radiation.γ 辐射诱导人外周血单个核细胞中 LINE-1 重复序列的全基因组甲基化及 DNA 损伤反应和修复相关基因启动子甲基化谱
Mol Cell Biochem. 2022 Jan;477(1):267-281. doi: 10.1007/s11010-021-04265-4. Epub 2021 Oct 27.
Expert Rev Mol Diagn. 2012 Jun;12(5):473-87. doi: 10.1586/erm.12.45.
4
ERCC1 and BRAC1 mRNA expression levels in the primary tumor could predict the effectiveness of the second-line cisplatin-based chemotherapy in pretreated patients with metastatic non-small cell lung cancer.原发肿瘤中 ERCC1 和 BRAC1 mRNA 表达水平可预测经治转移性非小细胞肺癌患者二线含铂化疗的疗效。
J Thorac Oncol. 2012 Apr;7(4):663-71. doi: 10.1097/JTO.0b013e318244bdd4.
5
Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.人类 DNA 修复基因的表观遗传学筛选鉴定出人头颈鳞状细胞癌中 NEIL1 启动子的异常甲基化。
Oncogene. 2012 Dec 6;31(49):5108-16. doi: 10.1038/onc.2011.660. Epub 2012 Jan 30.
6
No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia.慢性淋巴细胞白血病中ATM启动子CpG岛不存在DNA甲基化的证据。
Leuk Lymphoma. 2012 Jul;53(7):1420-2. doi: 10.3109/10428194.2011.653640. Epub 2012 Jan 31.
7
Genome-wide DNA methylation profiling using Infinium® assay.使用 Infinium® 分析进行全基因组 DNA 甲基化分析。
Epigenomics. 2009 Oct;1(1):177-200. doi: 10.2217/epi.09.14.
8
The implications of heterogeneous DNA methylation for the accurate quantification of methylation.异质 DNA 甲基化对甲基化精确定量的影响。
Epigenomics. 2010 Aug;2(4):561-73. doi: 10.2217/epi.10.32.
9
Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer.BRCA1、TXR1 和 TSP1 mRNA 表达与晚期/转移性非小细胞肺癌患者接受基于多西紫杉醇的一线化疗治疗结局的相关性。
Br J Cancer. 2011 Jan 18;104(2):316-23. doi: 10.1038/sj.bjc.6606027. Epub 2010 Dec 14.
10
Constitutional methylation of the BRCA1 promoter is specifically associated with BRCA1 mutation-associated pathology in early-onset breast cancer.BRCA1 启动子的甲基化与早发性乳腺癌中 BRCA1 突变相关病理学具有特异性相关性。
Cancer Prev Res (Phila). 2011 Jan;4(1):23-33. doi: 10.1158/1940-6207.CAPR-10-0212. Epub 2010 Oct 26.